This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (68)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David P. Mooney, MD; Richard L. Gamelli, MD; Michael O'Reilly; James C. Hebert, MD

Arch Surg. 1988;123(11):1353-1357.

Abstract
• Multiple immune defects have been demonstrated following thermal injury, including defective granulocyte production and function. Recombinant human granulocyte colony-stimulating factor (rhGCSF) is a regulator of the myelopoietic system. The effect of rhGCSF administration on survival and on the myelopoietic system in a murine model of Pseudomonas burn wound sepsis was investigated. Male BDF₁ mice that underwent a 15% total body surface area burn injury and burn wound seeding with 1 x 10⁸ Pseudomonas aeruginosa organisms demonstrated an improved mean survival time with the subcutaneous administration of 100 ng of rhGCSF twice a day. Mice that underwent a similar thermal injury and burn wound seeding with 3 x 10⁷ P aeruginosa organisms demonstrated an augmented myelopoietic response through the administration of rhGCSF, as represented by significantly increased white blood cell count, neutrophil count, splenic weight, femoral marrow cellularity, and femoral marrow granulocyte-macrophage colony-forming cell count. Myelopoietic augmentation through rhGCSF administration may serve to decrease the morbidity of septic events following thermal injury.

(Arch Surg 1988;123:1353-1357)

Author Affiliations
From the Department of Surgery, University of Vermont College of Medicine, Burlington.

Footnotes
Accepted for publication June 21, 1988.

Read before the Eighth Annual Meeting of the Surgical Infection Society, San Francisco, May 5, 1988.

Reprint requests to Department of Surgery, Given Building, University of Vermont College of Medicine, Burlington, VT 05405 (Dr Gamelli).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Production of Granulocyte Colony-Stimulating Factor in the Nonspecific Acute Phase Response Enhances Host Resistance to Bacterial Infection
Noursadeghi et al.
J. Immunol. 2002;169:913-919.
ABSTRACT | FULL TEXT  

Pretreatment with Granulocyte Colony-Stimulating Factor Attenuates the Inflammatory Response but Not the Bacterial Load in Cerebrospinal Fluid during Experimental Pneumococcal Meningitis in Rabbits
Ostergaard et al.
Infect. Immun. 1999;67:3430-3436.
ABSTRACT | FULL TEXT  

Biological Agents in Infectious Diseases
Louie and Jaresko
Journal of Pharmacy Practice 1991;4:326-341.
ABSTRACT  

Protective Effect of Recombinant Human Granulocyte Colony-Stimulating Factor Against Pneumococcal Infections in Splenectomized Mice
Hebert et al.
Arch Surg 1990;125:1075-1078.
ABSTRACT  

The Effect of Interleukin 1{alpha} on Survival in a Murine Model of Burn Wound Sepsis
Silver et al.
Arch Surg 1990;125:922-925.
ABSTRACT